Earnings summaries and quarterly performance for LENSAR.
Executive leadership at LENSAR.
Board of directors at LENSAR.
Research analysts who have asked questions during LENSAR earnings calls.
Recent press releases and 8-K filings for LNSR.
LENSAR, Inc. Reports Q3 2025 Results and Updates on Alcon Acquisition
LNSR
Earnings
M&A
Revenue Acceleration/Inflection
- LENSAR, Inc. reported total revenue of $14.3 million for the quarter ended September 30, 2025, an increase of 6% compared to the same period in 2024, primarily due to an 11% increase in worldwide procedure volume.
- The company recorded a net loss of $3.7 million, or ($0.31) per common share, for Q3 2025, largely attributable to $5.3 million in acquisition-related costs incurred in connection with the proposed merger with Alcon.
- During Q3 2025, LENSAR placed 18 ALLY Robotic Cataract Laser Systems, increasing the ALLY installed base to approximately 185 systems, representing a 77% increase over September 30, 2024.
- The proposed acquisition by Alcon is now expected to close in the first quarter of 2026, as the company continues to work with the U.S. Federal Trade Commission.
- As of September 30, 2025, LENSAR had $16.9 million in cash, cash equivalents, and investments.
Nov 6, 2025, 12:15 PM
Quarterly earnings call transcripts for LENSAR.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more